Arthritis Other

	09/29/2009	Molecular Mechanism of Cardiovascular Disease in Inflammatory Arthritis
	09/03/2009	Getting to the Root of Gout and Hyperuricemia: Core Principles in Diagnosis and Management for Rheumatologists
	08/26/2009	Ankylosing Spondylitis
	08/25/2009	Psoriatic Arthritis
	08/18/2009	The Epidemiology of Increased Cardiovascular Death in Inflammatory Arthritis
	07/24/2009	Exploring Psoriatic Arthritis: Bridging Dermatology and Rheumatology
	04/08/2009	Benefits of Early, Aggressive, and Appropriate Intervention in Rheumatoid Arthritis
	04/08/2009	The Rationale for Early Treatment in Rheumatoid Arthritis
	04/08/2009	Managing and Monitoring Response to RA Therapy
	04/08/2009	Applying Concepts to Practice in a Patient With Early Rheumatoid Arthritis
	03/30/2009	Moderate-to-Severe Psoriasis and Psoriatic Arthritis: Reducing the Clinical and Economic Burden Through Effective Treatment Protocols
	02/12/2009	Using Biologics to Improve Both Physical and Social Function in Rheumatic Diseases
	02/12/2009	Rheumatic Diseases: Using Anti-TNF-alpha Agents to Improve Everyday Patient Function
	02/12/2009	Treating to Target: Long-Term Safety and Efficacy in Rheumatoid Arthritis
	01/14/2009	Emerging Concepts in Treating Juvenile Idiopathic Arthritis
	11/27/2008	Diagnosis and New Treatments for Gout
	04/10/2008	Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
	04/10/2008	Long-Term Data on Abatacept and Rituximab Show Continued Efficacy in Rheumatoid Arthritis
	04/10/2008	Are Rituximab and Abatacept Safe Over the Long Term in Rheumatoid Arthritis?
	04/10/2008	Functional Assessment Effectively Measures Therapeutic Success in Rheumatoid Arthritis
	04/10/2008	Can HRQOL Be Sustained in the Long Term With Abatacept and Rituximab?
	01/18/2008	Latest Data Confirm That B- and T-Cell Targeted Therapies Are Robust Options for Refractory Rheumatoid Arthritis
	01/18/2008	Raising the Bar: Novel Anticytokines Expand Treatment Options in Rheumatoid Arthritis
	01/18/2008	New Guidelines: Task Force Expert Recommendations Address Use of Biologics in Rheumatoid Arthritis